Page last updated: 2024-11-07

penicillamine and Brain Neoplasms

penicillamine has been researched along with Brain Neoplasms in 14 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research Excerpts

ExcerptRelevanceReference
"To investigate the effects of copper (Cu)-depletion diet and D-penicillamine treatment (CDPT) on both tumor growth and angiogenesis, we studied Fischer-344 rats in which 9L gliosarcoma cells had been subcutaneously implanted."3.69Copper chelation inhibits tumor angiogenesis in the experimental 9L gliosarcoma model. ( Ikeda, Y; Nakazawa, S; Yoshida, D, 1995)
"Glioblastoma is a highly vascularized brain tumor, and antiangiogenic therapy improves its progression-free survival."1.39Role of collagen matrix in tumor angiogenesis and glioblastoma multiforme progression. ( Jiang, A; Jiang, E; Kieran, MW; Mammoto, A; Mammoto, T; Panigrahy, D, 2013)

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's11 (78.57)18.2507
2000's2 (14.29)29.6817
2010's1 (7.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mammoto, T1
Jiang, A1
Jiang, E1
Panigrahy, D1
Kieran, MW1
Mammoto, A1
Brem, S2
Grossman, SA1
Carson, KA1
New, P1
Phuphanich, S1
Alavi, JB1
Mikkelsen, T1
Fisher, JD1
Yoshida, D3
Ikeda, Y3
Nakazawa, S3
Jeitner, TM1
Renton, FJ1
Philipov, P1
Adami, A1
Crivellente, F1
De Prati, AC1
Cavalieri, E1
Cuzzolin, L1
Tommasi, M1
Suzuki, H1
Benoni, G1
Kurimoto, M1
Endo, S1
Hirashima, Y1
Hamada, H1
Ogiichi, T1
Takaku, A1
Matsumoto, H2
Hayashi, S2
Hatashita, M2
Shioura, H2
Ohtsubo, T2
Kitai, R2
Ohnishi, T2
Kano, E2
Ohnishi, K1
Vanchieri, C1
Brem, SS1
Zagzag, D2
Tsanaclis, AM2
Gately, S1
Elkouby, MP1
Brien, SE1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Phase II Study of Penicillamine and Reduction of Copper for Angiosuppressive Therapy of Adults With Newly Diagnosed Glioblastoma[NCT00003751]Phase 240 participants (Anticipated)Interventional1999-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for penicillamine and Brain Neoplasms

ArticleYear
Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma.
    Neuro-oncology, 2005, Volume: 7, Issue:3

    Topics: Brain Neoplasms; Chelating Agents; Copper; Diet Therapy; Female; Glioblastoma; Humans; Male; Middle

2005

Other Studies

13 other studies available for penicillamine and Brain Neoplasms

ArticleYear
Role of collagen matrix in tumor angiogenesis and glioblastoma multiforme progression.
    The American journal of pathology, 2013, Volume: 183, Issue:4

    Topics: Animals; Brain; Brain Neoplasms; Cell Count; Cell Line, Tumor; Collagen; Disease Progression; Gliobl

2013
Copper chelation inhibits tumor angiogenesis in the experimental 9L gliosarcoma model.
    Neurosurgery, 1995, Volume: 37, Issue:2

    Topics: Animals; Brain Neoplasms; Cell Division; Cell Line; Chelating Agents; Copper; Gliosarcoma; Male; Mic

1995
Suppression of tumor growth in experimental 9L gliosarcoma model by copper depletion.
    Neurologia medico-chirurgica, 1995, Volume: 35, Issue:3

    Topics: Animals; Brain Neoplasms; Copper; Gliosarcoma; Male; Penicillamine; Rats; Rats, Inbred F344

1995
Suppression of 9L gliosarcoma growth by copper depletion with copper-deficient diet and D-penicillamine.
    Journal of neuro-oncology, 1993, Volume: 17, Issue:2

    Topics: Animals; Brain Chemistry; Brain Neoplasms; Copper; Gliosarcoma; Male; Neoplasm Transplantation; Peni

1993
Inhibition of the proliferation of human neural neoplastic cell lines by cysteamine.
    Cancer letters, 1996, May-15, Volume: 103, Issue:1

    Topics: Blood-Brain Barrier; Brain Neoplasms; Cell Cycle; Cell Division; Cell Line; Cysteamine; DNA, Neoplas

1996
Suppression of tumor growth in experimental 9L gliosarcoma model by copper depletion.
    Neurologia medico-chirurgica, 1996, Volume: 36, Issue:2

    Topics: Brain Neoplasms; Chelating Agents; Deferoxamine; Glioma; Humans; Penicillamine; Trace Elements

1996
Biotransformation and cytotoxic properties of NO-donors on MCF7 and U251 cell lines.
    Life sciences, 1998, Volume: 63, Issue:23

    Topics: Biotransformation; Brain Neoplasms; Breast Neoplasms; Cell Survival; Enzyme Inhibitors; Female; Glio

1998
Growth inhibition and radiosensitization of cultured glioma cells by nitric oxide generating agents.
    Journal of neuro-oncology, 1999, Volume: 42, Issue:1

    Topics: Animals; Brain Neoplasms; Cell Division; Cell Survival; Dose-Response Relationship, Radiation; Gliom

1999
Intercellular signaling initiated by nitric oxide produced in heat-shocked human glioblastoma cells.
    Nitric oxide : biology and chemistry, 1999, Volume: 3, Issue:2

    Topics: Brain Neoplasms; Culture Media; Glioblastoma; Heat-Shock Proteins; Heat-Shock Response; HSP72 Heat-S

1999
Nitric oxide is an initiator of intercellular signal transduction for stress response after hyperthermia in mutant p53 cells of human glioblastoma.
    Cancer research, 1999, Jul-01, Volume: 59, Issue:13

    Topics: Benzoates; Brain Neoplasms; Cell Division; Coculture Techniques; Genes, p53; Glioblastoma; Guanidine

1999
Cutting copper curbs angiogenesis, studies show.
    Journal of the National Cancer Institute, 2000, Aug-02, Volume: 92, Issue:15

    Topics: Angiogenesis Inhibitors; Brain Neoplasms; Chelating Agents; Clinical Trials as Topic; Combined Modal

2000
Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor.
    The American journal of pathology, 1990, Volume: 137, Issue:5

    Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Capillary Permeability; Cell Division; Copper; Diet; Fi

1990
Anticopper treatment inhibits pseudopodial protrusion and the invasive spread of 9L gliosarcoma cells in the rat brain.
    Neurosurgery, 1990, Volume: 26, Issue:3

    Topics: Animals; Brain Neoplasms; Copper; Glioma; Male; Microscopy, Electron; Neoplasm Transplantation; Peni

1990